STOCK TITAN

GEVO SEC Filings, May 29, 2026

GEVO NASDAQ

Gevo, Inc. filings document the company’s renewable-fuels business, Nasdaq-listed common stock, operating results and material corporate events. Form 8-K reports include quarterly and annual financial results, business updates for low-carbon ethanol, carbon management, synthetic aviation fuel initiatives, and material financing or refinancing arrangements involving company subsidiaries.

Proxy and governance filings cover director elections, board composition, auditor ratification, executive compensation votes and officer transitions. The filing record also documents credit agreements, working-capital facilities, renewable natural gas project debt matters, compensatory arrangements and other disclosures related to Gevo’s capital structure, governance and project-development strategy.

Rhea-AI Summary

Guillen Jaime reported acquisition or exercise transactions in this Form 4 filing.

Gevo, Inc. director Jaime Guillen received a grant of 70,000 shares of restricted common stock on May 27, 2026. These shares vest at the earlier of the next annual meeting of stockholders or the first anniversary of the grant, contingent on continued service. Following this award, Guillen directly holds 264,046 common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
-
Rhea-AI Summary

Ellet Mary Kathryn reported acquisition or exercise transactions in this Form 4 filing.

Gevo, Inc. director Mary Kathryn Ellet reported receiving a grant of 70,000 shares of common stock as equity compensation. The award was priced at $0.00 per share, indicating it is a restricted stock grant rather than an open-market purchase.

The restricted common stock will vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date, provided Ellet remains in continuous service with Gevo through the vesting date. Following this award, she directly holds 132,821 shares of Gevo common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
-
Rhea-AI Summary

Gevo, Inc. director William H. Baum received a grant of 80,893 stock options linked to the company’s common stock. The options have an exercise price of $1.80 per share and expire on May 26, 2036. They vest at the earlier of the next annual shareholder meeting or the first anniversary of the grant, assuming he remains in continuous service. Following this grant, he holds 80,893 options directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
Rhea-AI Summary

Barber James J reported acquisition or exercise transactions in this Form 4 filing.

Gevo, Inc. director James J. Barber received a grant of 70,000 shares of common stock as equity compensation. The award is in the form of restricted common stock that was granted at a stated price of $0.00 per share.

The restricted shares vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date, as long as Barber remains in continuous service with Gevo through the vesting date. After this grant, he directly holds 70,000 shares of Gevo common stock as reported in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
-
Rhea-AI Summary

Gevo, Inc. director Patrick R. Gruber reported a mix of equity compensation and related share sales. He was granted 70,000 shares of restricted common stock at no cost, which vest on the earlier of the next annual stockholder meeting or the first anniversary of the grant, if he remains in continuous service. To cover tax withholding obligations from a restricted stock vesting, he sold 186,469 shares of common stock at a weighted average price of $1.7598 per share, in multiple trades between $1.74 and $1.80, under a pre-arranged Rule 10b5-1 trading plan adopted on November 19, 2025. Following these transactions, he holds 3,728,993 shares directly and 25,757.94 shares indirectly through Gevo’s 401(k) plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
-
Rhea-AI Summary

Gevo, Inc. officer Andrew Shafer reported routine share activity. On May 27, 2026, he sold 32,667 shares of common stock at a weighted average price of $1.7598 per share to cover tax withholding obligations upon vesting of a restricted stock award, under a pre-arranged Rule 10b5-1 trading plan. After this sale, he directly holds 321,051 shares of Gevo common stock. He also indirectly holds 16,858.96 shares through the company’s 401(k) plan, where a total of 6.29 shares were disposed of between May 20 and May 27, 2026 to pay administrative fees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
Rhea-AI Summary

Gevo, Inc. Chief of Staff Kimberly T. Bowron reported an open-market sale of 25,101 shares of common stock at a weighted average price of $1.7598 per share on May 27, 2026. According to the footnotes, these shares were sold to cover tax withholding obligations upon the vesting of a restricted stock award and were executed under a Rule 10b5-1 trading plan adopted on November 20, 2025.

Following the sale, Bowron directly holds 711,765 shares of Gevo common stock. She also indirectly holds 14,973.97 shares through a 401(k) plan, where a separate disposal of 5.59 shares between May 20 and May 27, 2026 was made to cover plan administrative fees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
-
Rhea-AI Summary

Gevo, Inc. CFO Agiri Oluwagbemileke Yusuf reported an open-market sale of common stock. On May 27, 2026, he sold 31,958 shares at a weighted average price of $1.7727 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.

After the sale, he directly held 554,144 shares of Gevo common stock. Indirectly, through the company’s 401(k) plan, he held 24,863.89 shares, with 9.37 shares previously disposed of between May 20 and May 27, 2026 to cover plan administrative fees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
-
Rhea-AI Summary

Gevo, Inc. President & COO Ryan Christopher Michael reported an open-market sale of 87,700 shares of common stock at a weighted average price of $1.7598 per share. According to the filing, these shares were sold to cover tax withholding obligations upon vesting of a restricted stock award and were executed under a Rule 10b5-1 trading plan adopted on November 19, 2025. After the sale, he directly holds 1,314,441 shares of common stock and indirectly holds 27,868.19 shares through a 401(k) plan, which reflects disposals of 20.76 shares between March 30, 2026 and May 27, 2026 to cover administrative fees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider
Rhea-AI Summary

Gevo, Inc. director and CEO Paul D. Bloom reported transactions in the company’s common stock linked to compensation and plan administration. He sold 75,735 shares at a weighted average price of $1.7598 per share to cover tax withholding obligations upon the vesting of a restricted stock award. These sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 22, 2025.

Following the sale, Bloom directly holds 1,518,588 shares of Gevo common stock. Separately, he holds 28,123.51 shares indirectly through a 401(k) plan, after disposing of 10.54 shares between May 20, 2026 and May 27, 2026 to cover plan administrative fees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
insider

FAQ

How many Gevo (GEVO) SEC filings are available on StockTitan?

StockTitan tracks 170 SEC filings for Gevo (GEVO), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Gevo (GEVO)?

The most recent SEC filing for Gevo (GEVO) was filed on November 10, 2026.